Pfizer Inc., US7170811035

EUR 25.33 at Lang & Schwarz: Pfizer stock pre-market plus 0.04 percent versus the Xetra close

Published on 10/14/2026 at 08:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Pfizer stock is at EUR 25.33 pre-market at Lang & Schwarz on October 14, 2026. The 52-week high is EUR 25.60.

Dates and valuation before trading

  • The current trading date is October 14, 2026.
  • Pfizer stock trades pre-market at EUR 25.33 at 8:07 a.m. CEST at Lang & Schwarz on October 14, 2026, 0.04 percent above the Xetra close of October 13, 2026.
  • Pfizer's price-earnings ratio is 37.49 as of October 13, 2026.
Pfizer Inc., US7170811035, Illustration mit AI erstellt.

Pfizer stock is at EUR 25.33 in pre-market trading at Lang & Schwarz at 8:07 a.m. CEST on October 14, 2026. That is 0.04 percent above the Xetra close of October 13, 2026, at EUR 25.32. The quote is ahead of the Xetra session scheduled to begin at 9:00 a.m. CEST.

Pre-market price and trading range

Lang & Schwarz shows a bid of EUR 25.27 and an ask of EUR 25.39. The current indication remains below Pfizer's 52-week high of EUR 25.60 and above its 52-week low of EUR 20.52. The high is 1.07 percent above the current pre-market price, calculated from the unrounded values. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Pfizer stock.

What matters today

The current trading date is October 14, 2026. Pfizer's 52-week high is EUR 25.60, representing a 1.07 percent distance from the pre-market price. The company's price-earnings ratio is 37.49 as of October 13, 2026.

Valuation reference

The finance quote for Pfizer Inc. in euros was timestamped October 13, 2026, at 3:35 p.m. UTC, when the market status was closed. Its reported price-earnings ratio was 37.49, while the trailing dividend yield was 6.00 percent. The current Lang & Schwarz indication is therefore presented separately from the dated valuation figures and the Xetra reference close.

Market context: Market report S&P 500.

More news and analysis on Pfizer stock

Disclaimer...
en | US7170811035 | PFIZER INC. | boerse | 70321012 | bgmi